Kigen Kondo

1.3k total citations
33 papers, 1.1k citations indexed

About

Kigen Kondo is a scholar working on Pharmacology, Organic Chemistry and Biochemistry. According to data from OpenAlex, Kigen Kondo has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 13 papers in Organic Chemistry and 12 papers in Biochemistry. Recurrent topics in Kigen Kondo's work include Inflammatory mediators and NSAID effects (19 papers), Eicosanoids and Hypertension Pharmacology (11 papers) and Estrogen and related hormone effects (7 papers). Kigen Kondo is often cited by papers focused on Inflammatory mediators and NSAID effects (19 papers), Eicosanoids and Hypertension Pharmacology (11 papers) and Estrogen and related hormone effects (7 papers). Kigen Kondo collaborates with scholars based in Japan, United States and United Kingdom. Kigen Kondo's co-authors include Shuichi Ohuchida, Takayuki Maruyama, Osamu Hayaishi, Takao Shimizu, Hiroshi Yamamoto, Toshihiko Kawamori, Seiichi Nakatsugi, Kouji Watanabe, Kosei Ito and Teruaki Katayama and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Kigen Kondo

33 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kigen Kondo Japan 16 528 339 206 202 183 33 1.1k
Lutz Bräutigam Germany 10 553 1.0× 283 0.8× 206 1.0× 108 0.5× 148 0.8× 12 954
Sandra Austin United States 12 675 1.3× 365 1.1× 152 0.7× 144 0.7× 78 0.4× 15 1.4k
M. Lecomte France 15 330 0.6× 342 1.0× 177 0.9× 102 0.5× 60 0.3× 37 982
Makoto Katori Japan 15 378 0.7× 285 0.8× 112 0.5× 148 0.7× 68 0.4× 53 955
James D. Eskra United States 17 358 0.7× 206 0.6× 97 0.5× 146 0.7× 81 0.4× 30 921
Charlotte Edenius Sweden 19 276 0.5× 280 0.8× 51 0.2× 285 1.4× 51 0.3× 40 1.1k
Noe Gonzales United States 17 190 0.4× 534 1.6× 101 0.5× 258 1.3× 39 0.2× 21 1.2k
Gregory J. Dusting Australia 17 384 0.7× 229 0.7× 57 0.3× 322 1.6× 29 0.2× 24 1.1k
Banumathi K. Cole United States 20 117 0.2× 580 1.7× 119 0.6× 283 1.4× 42 0.2× 26 1.7k
Françoise Pecker France 20 138 0.3× 809 2.4× 63 0.3× 196 1.0× 47 0.3× 33 1.7k

Countries citing papers authored by Kigen Kondo

Since Specialization
Citations

This map shows the geographic impact of Kigen Kondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kigen Kondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kigen Kondo more than expected).

Fields of papers citing papers by Kigen Kondo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kigen Kondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kigen Kondo. The network helps show where Kigen Kondo may publish in the future.

Co-authorship network of co-authors of Kigen Kondo

This figure shows the co-authorship network connecting the top 25 collaborators of Kigen Kondo. A scholar is included among the top collaborators of Kigen Kondo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kigen Kondo. Kigen Kondo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Naganawa, Atsushi, Kōji Yoshida, Hiroshi Tsuruta, et al.. (2006). Optimization of sulfonamide derivatives as highly selective EP1 receptor antagonists. Bioorganic & Medicinal Chemistry. 14(23). 7774–7789. 9 indexed citations
2.
Yoshida, Keiji, Hiroji Oida, Takuya Kobayashi, et al.. (2002). Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proceedings of the National Academy of Sciences. 99(7). 4580–4585. 273 indexed citations
3.
Maruyama, Toru, Shin‐itsu Kuwabe, Tai Shiraishi, et al.. (2002). Design and synthesis of a selective EP4-receptor agonist. Part 4: practical synthesis and biological evaluation of a novel highly selective EP4-receptor agonist. Bioorganic & Medicinal Chemistry. 10(7). 2103–2110. 21 indexed citations
4.
Tani, Kousuke, Atsushi Naganawa, Kenji Sagawa, et al.. (2002). Development of a highly selective EP2-receptor agonist. Part 2: identification of 16-Hydroxy-17,17-trimethylene 9β-chloro PGF derivatives. Bioorganic & Medicinal Chemistry. 10(4). 1107–1114. 13 indexed citations
5.
Tani, Kousuke, Atsushi Naganawa, Kenji Sagawa, et al.. (2002). Development of a highly selective EP2-receptor agonist. Part 1: identification of 16-hydroxy-17,17-trimethylene PGE2 derivatives. Bioorganic & Medicinal Chemistry. 10(4). 1093–1106. 16 indexed citations
6.
Maruyama, Toru, Masaki Asada, Tai Shiraishi, et al.. (2002). Design and synthesis of a selective EP4-Receptor agonist. Part 1: discovery of 3,7-DithiaPGE1 derivatives and identification of Their ω chains. Bioorganic & Medicinal Chemistry. 10(4). 975–988. 4 indexed citations
7.
Maruyama, Toru, Masaki Asada, Tai Shiraishi, et al.. (2002). Design and Synthesis of a Selective EP4-Receptor Agonist. Part 2: 3,7-DithiaPGE1 Derivatives with High Selectivity. Bioorganic & Medicinal Chemistry. 10(4). 989–1008. 11 indexed citations
8.
Kawamori, Toshihiko, Seiichi Nakatsugi, Kouji Watanabe, et al.. (2001). Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP1 antagonist, on breast cancer development. Carcinogenesis. 22(12). 2001–2004. 76 indexed citations
9.
Tani, Kousuke, Atsushi Naganawa, Kenji Sagawa, et al.. (2001). Design and Synthesis of a Highly Selective EP2-Receptor Agonist. Bioorganic & Medicinal Chemistry Letters. 11(15). 2025–2028. 37 indexed citations
10.
Maruyama, Toru, Masaki Asada, Tai Shiraishi, et al.. (2001). Design and synthesis of a highly selective EP4-receptor agonist. Part 2: 5-thia and 9β-haloPG derivatives with improved stability. Bioorganic & Medicinal Chemistry Letters. 11(15). 2033–2035. 11 indexed citations
11.
Maruyama, Toru, Masaki Asada, Tai Shiraishi, et al.. (2001). Design and synthesis of a highly selective EP4-receptor agonist. part 1: 3,7-dithiaPG derivatives with high selectivity. Bioorganic & Medicinal Chemistry Letters. 11(15). 2029–2031. 18 indexed citations
12.
Katsube, Nobuo, et al.. (2001). Model of neuropathic intermittent claudication in the rat: methodology and application. Journal of Neuroscience Methods. 104(2). 191–198. 39 indexed citations
13.
Watanabe, Kouji, Toshihiko Kawamori, Seiichi Nakatsugi, et al.. (2000). Inhibitory effect of a prostaglandin E receptor subtype EP1 selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice. Cancer Letters. 156(1). 57–61. 99 indexed citations
14.
Kobayashi, Kaoru, Yoshihisa Kamanaka, Ryo Yanase, et al.. (2000). A Potent Inhibitor of Inducible Nitric Oxide Synthase, ONO-1714, a Cyclic Amidine Derivative. Biochemical and Biophysical Research Communications. 270(2). 663–667. 87 indexed citations
15.
Hamanaka, Nobuyuki, et al.. (1996). Novel Nonprostanoid Prostacyclin (PGI2) Mimetics with Heterocyclic Moiety. Heterocycles. 42(2). 517–517. 3 indexed citations
16.
17.
Hamanaka, Nobuyuki, et al.. (1995). Molecular design of novel PGI2 agonists without PG skeleton. IV. Bioorganic & Medicinal Chemistry Letters. 5(10). 1083–1086. 11 indexed citations
18.
Kondo, Kigen, et al.. (1989). Effects of ONO-3708, an antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on platelet aggregation and thrombosis. European Journal of Pharmacology. 163(2-3). 253–261. 18 indexed citations
19.
Kondo, Kigen, Jane A. Mitchell, Gilberto De Nucci, & John R. Vane. (1989). Simultaneous measurement of endothelium‐derived relaxing factor by bioassay and guanylate cyclase stimulation. British Journal of Pharmacology. 98(2). 630–636. 27 indexed citations
20.
Kondo, Kigen, Takao Shimizu, & Osamu Hayaishi. (1981). Effects of prostaglandin D2 on membrane potential in neuroblastoma X glioma hybrid cells as determined with a cyanine dye. Biochemical and Biophysical Research Communications. 98(3). 648–655. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lutz Bräutigam Breakdown of academic impact, for papers by Sandra Austin Breakdown of academic impact, for papers by M. Lecomte Breakdown of academic impact, for papers by Makoto Katori Breakdown of academic impact, for papers by James D. Eskra Breakdown of academic impact, for papers by Charlotte Edenius Breakdown of academic impact, for papers by Noe Gonzales Breakdown of academic impact, for papers by Gregory J. Dusting Breakdown of academic impact, for papers by Banumathi K. Cole Breakdown of academic impact, for papers by Françoise Pecker
Rankless by CCL
2026